Liquid biopsies come of age: towards implementation of circulating tumour DNA

Jonathan C. M. Wan(Cancer Research UK), Charles Massie(Cancer Research UK Cambridge Center), Javier García-Corbacho(Hospital Clínic de Barcelona), Florent Moulière(Cancer Research UK), James D. Brenton(Cancer Research UK Cambridge Center), Carlos Caldas(Cancer Research UK Cambridge Center), Simon Pacey(Cancer Research UK Cambridge Center), Richard D. Baird(Cancer Research UK Cambridge Center), Nitzan Rosenfeld(Cancer Research UK)
Nature reviews. Cancer
February 24, 2017
10.1038/nrc.2017.7
Cited by 2,657Open Access
Full Text

Abstract

Related Papers

Free DNA in the serum of cancer patients and the effect of therapy.
Shalom A. Leon, B Shapiro, D.M. Sklaroff et al.|PubMed|1977|1.8k
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip et al.|Nature Medicine|2015|1.5k
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy Yates, Moritz Gerstung, Stian Knappskog et al.|Nature Medicine|2015|838
About the possible origin and mechanism of circulating DNA
Maurice Stroun, Jacqueline Lyautey, C Lederrey et al.|Clinica Chimica Acta|2001|724
Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill et al.|PLoS ONE|2015|713